🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Chuck Royce’s ABVX Holdings & Trades

First Buy
Q2 2026
Duration Held
2 Quarters
Largest Add
Q2 2026
+45,103 Shares
Current Position
61,251 Shares
$6.07 M Value

Chuck Royce's ABVX Position Overview

Chuck Royce (via Royce & Associates Lp) currently holds 61,251 shares of ABIVAX Société Anonyme (ABVX) worth $6.07 M, representing 0.06% of the portfolio. First purchased in 2026-Q2, this recently established position has been held for 2 quarters.

Based on recent 13F filings, Chuck Royce has initiated a new position in ABVX, representing a fresh investment thesis on this company. Largest addition occurred in Q3 2026, adding 16,148 shares.

Analysis based on 13F filings available since 2013 Q2

Chuck Royce's ABIVAX Société Anonyme (ABVX) Holding Value Over Time

Track share changes against reported price movement

Quarterly ABIVAX Société Anonyme (ABVX) Trades by Chuck Royce

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q3 2026 +16,148 Add 35.80% 61,251 $99.02
Q2 2026 +45,103 New Buy 45,103 $133.26

Chuck Royce's ABIVAX Société Anonyme Investment FAQs

Chuck Royce first purchased ABIVAX Société Anonyme (ABVX) in Q2 2026, acquiring 45,103 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Chuck Royce has held ABIVAX Société Anonyme (ABVX) for 2 quarters since Q2 2026.

Chuck Royce's largest addition to ABIVAX Société Anonyme (ABVX) was in Q2 2026, adding 45,103 shares worth $6.01 M.

According to the latest 13F filing for Q3 2026, Chuck Royce's firm, Royce & Associates Lp, owns 61,251 shares of ABIVAX Société Anonyme (ABVX), valued at approximately $6.07 M.

As of the Q3 2026 filing, ABIVAX Société Anonyme (ABVX) represents approximately 0.06% of Chuck Royce's publicly disclosed stock portfolio, making it one of their key holdings.

Chuck Royce's peak holding in ABIVAX Société Anonyme (ABVX) was 61,251 shares, as reported at the end of Q3 2026.